Cannabis Testing Market to surpass USD 2 Billion by 2025: Global Market Insights, Inc.

Global Market Insights, Inc

The Cannabis Testing Market revenue is set to rise from US$ 1 billion in 2018 to around USD 2 billion by 2025, according to a 2019 Global Market Insights, Inc. report. Growing application of cannabis in various medical conditions such as rare and severe epilepsy, chronic pain, and to reduce nausea and vomiting after chemotherapy will fuel the demand for cannabis globally. This increase in demand for cannabis has led the authorization of cannabis for medical purposes in various countries, thereby necessitating cannabis quality control test. Furthermore, increasing approvals of cannabis product along with extensive R&D programs will boost the cannabis testing market growth in the forthcoming period.

Increasing number of testing laboratories in developed countries will fuel market growth. Additionally, increasing awareness programs such as conferences, symposia and workshops in developed regions to educate the people and government regarding medical use of cannabis will boost the industry growth. Also, need for more testing laboratories to meet the demand for growing cannabis cultivators will boost market growth across the forecast timeframe.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3567

However, strict regulatory policies and lack of trained laboratory professionals will pose a negative impact on cannabis testing market size. Additionally, high cost of analytical instruments and lack of standardization throughout the industry will hamper the growth of the industry over the forecast period.

Chromatography technology segment will account for revenue of USD 1.5 billion by 2025. The cannabis testing market growth will be attributed to the application of chromatography techniques in potency testing of cannabis. Gas chromatography and liquid chromatography are often preferred for potency analysis due to its speed and simplicity. Additionally, samples are tested at room temperature and do not undergo heat-catalyzed reactions. Aforementioned advantages of chromatography will increase its adoption over the foreseeable period.

Potency testing will expand at 13.9% CAGR from 2019 to 2025. Potency testing is used to measure the concentration of cannabinoids in samples. Cannabinoids potency screening is mainly employed by quality control laboratories and chemists. Moreover, potency research is essential for precise labeling of medical products. Thus, increasing applications of cannabinoids for medical purpose will spur the demand for cannabinoid potency testing.

Browse key industry insights spread across 180 pages with 318 market data tables & 8 figures & charts from the report, “Cannabis Testing Market Size By Technology (Chromatography {Liquid Chromatography, Gas Chromatography}, Spectroscopy {Mass Spectrometry, Atomic Spectroscopy}), By Test Type (Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing), By Service Provider (Laboratories, Manufacturers, Research Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, Italy, France, Belgium, Czech Republic, Denmark, Finland, Greece, Ireland, Norway, Poland, The Netherlands, Argentina, Brazil, Chile, Colombia, Mexico, Australia, Israel, Turkey), Application Potential, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents: 

https://www.gminsights.com/industry-analysis/cannabis-testing-market

Cannabis testing market share from laboratories segment accounted for 57.8% share in 2018 and will dominate the service provider category over the forecast timeframe due to availability of appropriate analytical testing tools. The advanced technologies provided by laboratories along with standard procedures that enable proper cannabis testing will positively impact the growth in laboratories.

U.S. cannabis testing market will grow at a significant pace of 5% CAGR owing to the authorization of cannabis for medical and recreational purposes in the country. At present, cannabis is legalized in 33 states of the U.S for medical purpose. Increasing awareness programs in the U.S. including conferences and workshops conducted to educate people related to the medical use of marijuana will further pose lucrative cannabis testing market growth. For instance, the World Medical Cannabis Conference and Expo is the largest cannabis conference that was held in March 2019 at Pennsylvania to provide support for the rapidly developing medical cannabis industry.

Chile cannabis testing market share accounted for 61.7% in 2018 and is expected to grow at a significant pace due to increase in use of cannabis for medical purpose and growing awareness of medical use of cannabis in developing countries. Moreover, key players are introducing innovative technologies in the country and exploring the untapped opportunities, thereby positively impacting Chile market.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3567

Few of the prominent industry competitors involved in the global cannabis testing market share are Anandia Labs, Anresco, CannaSafe Analytics, CW Analytical Laboratories, Digipath, Eirlab, EVIO, Phytovista Laboratories, Pure Analytics, SC Labs, and Steep Hill. The industry players emphasize on acquisitions, mergers & partnerships as well as new service developments to strengthen their position in the market. For instance, in January 2019, Digipath, Inc., announced plans to expand its testing services in Colombia. This will enable the company to broaden its customer base and generate strong revenues.

Browse Related Reports:

1. U.S. Medical Marijuana Market Size By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures, Others), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Regional Outlook (North East {Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania}, East North Central {Illinois, Michigan}, South Atlantic {Delaware, Florida, Maryland, Washington, D.C.}, West North Central {Minnesota}, Pacific Central {Alaska, California, Hawaii, Oregon, Washington}, Mountain States {Arizona, Colorado, Nevada, New Mexico, Montana}), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

https://www.gminsights.com/industry-analysis/us-medical-marijuana-market

2. Companion Diagnostics Market Size By Product (Instruments, Consumables, Services), By Disease Indication (Breast cancer, Lung cancer, Colorectal Cancer, Skin cancer), By Technology (Immunohistochemistry, In Situ Hybridization, Polymerase Chain Reaction, Genetic Sequencing), By End-use (Hospitals, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, India, China, Japan, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2019 - 2025

https://www.gminsights.com/industry-analysis/companion-diagnostics-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Sean Doyle